Therapies that unleash the immune system to fight tumors have greatly extended the lives of people with many types of cancer.

Jocelyn and Kristofer Carella-Erickson detail their traumatic back-to-back cancer experiences with PEOPLE — and say their ...

Dr. Lillian L. Siu discussed potential risk factors and treatment strategies associated for patients with head and neck ...

Discover how a recent meta-analysis showed VEIL improves perioperative outcomes compared to OIL in penile cancer treatment.

The research team, led by Professor Tu Wenwei (second right) and Professor Wang Weiping (second left), has made a ...

Four leading companies CTMC, Iovance Therapeutics, KSQ, and TILT Biotherapeutics prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities.

Humira is a type of immunosuppressant known as a tumor necrosis factor (TNF) inhibitor. It's used to treat several types of ...

A team of scientists from the Institute of Advanced Study in Science and Technology (IASST), an autonomous institute of the ...

Pancreatic cancer is on the rise in the United States, but there's another, less common type called pancreatic neuroendocrine ...

A new study shows that MXene-based nanozymes enhance cancer treatment by combining catalytic activity with electrical pulses, ...

For superficial skin cancers, Mohs surgery can be a definitive procedure, but nonsurgical approaches are competitive in the ...

Breast cancer is one of the leading causes of mortality among women worldwide. Tumor necrosis factor α-induced protein 3-interacting protein 1 (TNIP1) is a ubiquitin-binding protein that is ...